Ibuprofen Orifarm (Ibuprofen)

Ibuprofen works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for prostaglandin production. Lower prostaglandin levels result in decreased inflammation, reduced pain signaling, and a lowered fever response.

The appropriate dose of Ibuprofen Orifarm is determined by the prescribing clinician based on the patient’s condition, age, weight and overall health. Patients should follow the prescriber’s instructions and never adjust the dose on their own.

Safety data for ibuprofen during pregnancy and lactation are limited. It should only be used if the potential benefit outweighs the risk, and under the guidance of a healthcare professional. Women who are pregnant, especially in the third trimester, or who are breastfeeding should discuss alternatives with their doctor.

To order Ibuprofen Orifarm, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibuprofen shares the same class mechanism as other NSAIDs such as naproxen or diclofenac, offering comparable analgesic and anti‑inflammatory effects. Differences may include duration of action, dosing frequency, and individual tolerability. The choice of NSAID often depends on patient-specific factors and physician preference.

Ibuprofen Orifarm should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date indicated on the label.

Ibuprofen Orifarm is taken orally, usually with a full glass of water. It can be taken with or without food; however, taking it with food or milk may reduce gastrointestinal discomfort. Follow the prescriber’s directions regarding timing and frequency.

Serious risks include gastrointestinal bleeding or ulceration, acute kidney injury, and cardiovascular events such as heart attack or stroke, especially with high‑dose or prolonged use. Patients should be monitored for signs of these conditions and seek medical attention if they occur.

Ibuprofen Orifarm should be avoided in individuals with known hypersensitivity to ibuprofen or other NSAIDs, active peptic ulcer disease, severe heart failure, uncontrolled hypertension, and in the third trimester of pregnancy. Consultation with a healthcare professional is essential before starting therapy.